Targeting the Temporal Dynamics of Hypoxia-Induced Tumor-Secreted Factors Halts Tumor Migration
- 1 June 2019
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 79 (11) , 2962-2977
Abstract
Targeting microenvironmental factors that foster migratory cell phenotypes is a promising strategy for halting tumor migration. However, lack of mechanistic understanding of the emergence of migratory phenotypes impedes pharmaceutical drug development. Using our three-dimensional microtumor model with tight control over tumor size, we recapitulated the tumor size–induced hypoxic microenvironment and emergence of migratory phenotypes in microtumors from epithelial breast cells and patient-derived primary metastatic breast cancer cells, mesothelioma cells, and lung cancer xenograft cells. The microtumor models from various patient-derived tumor cells and patient-derived xenograft cells revealed upregulation of tumor-secreted factors, including matrix metalloproteinase-9 (MMP9), fibronectin (FN), and soluble E-cadherin, consistent with clinically reported elevated levels of FN and MMP9 in patient breast tumors compared with healthy mammary glands. Secreted factors in the conditioned media of large microtumors induced a migratory phenotype in nonhypoxic, nonmigratory small microtumors. Subsequent mathematical analyses identified a two-stage microtumor progression and migration mechanism whereby hypoxia induces a migratory phenotype in the initialization stage, which then becomes self-sustained through a positive feedback loop established among the tumor-secreted factors. Computational and experimental studies showed that inhibition of tumor-secreted factors effectively halts microtumor migration despite tumor-to-tumor variation in migration kinetics, while inhibition of hypoxia is effective only within a time window and is compromised by tumor-to-tumor variation, supporting our notion that hypoxia initiates migratory phenotypes but does not sustain it. In summary, we show that targeting temporal dynamics of evolving microenvironments, especially tumor-secreted factors during tumor progression, can halt tumor migration. Significance: This study uses state-of-the-art three-dimensional microtumor models and computational approaches to highlight the temporal dynamics of tumor-secreted microenvironmental factors in inducing tumor migration.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI) (R37CA232209)
- HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI) (R37CA232209)
- HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI) (R37CA232209)
- HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI) (R37CA232209)
- NSF | MPS | Division of Mathematical SciencesNSF | MPS | Division of Mathematical Sciences (DMS) (DMS-1462049)
- Pennsylvania Department of HealthPennsylvania Department of Health (PDH) (SAP 4100062224)
- DOD | Congressionally Directed Medical Research ProgramsDOD | Congressionally Directed Medical Research Programs (CDMRP) (BC032981,BC044784,W81XWH-12-1-0415,BC132245_W81XWH-14-0258)
- University of PittsburghUniversity of Pittsburgh (Pitt) (No grant number)
- University of Pittsburgh Cancer InstituteUniversity of Pittsburgh Cancer Institute (UPCI) (CCSG P30CA047904)
This publication has 54 references indexed in Scilit:
- Flow cytometric determination of stem/progenitor content in epithelial tissues: An example from nonsmall lung cancer and normal lungCytometry Part A, 2012
- Dishonorable Discharge: The Oncogenic Roles of Cleaved E-Cadherin FragmentsCancer Research, 2012
- Clonal evolution in cancerNature, 2012
- Use of Gel Zymography to Examine Matrix Metalloproteinase (Gelatinase) Expression in Brain Tissue or in Primary Glial Cultures2011
- Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic ConditionsJournal of Breast Cancer, 2011
- Stabilization of Hypoxia-inducible Factor-1α Protein in Hypoxia Occurs Independently of Mitochondrial Reactive Oxygen Species ProductionJournal of Biological Chemistry, 2010
- Cancer secretomics reveal pathophysiological pathways in cancer molecular oncologyMolecular Oncology, 2010
- Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003Journal of Clinical Oncology, 2008
- The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor ActivationJournal of Biological Chemistry, 2008
- Effects of Reoxygenation on Cells From Hypoxic Regions of Solid Tumors: Anticancer Drug Sensitivity and Metastatic PotentialJNCI: Journal of the National Cancer Institute, 1990